Welcome

VentiRx Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company committed to the development and commercialization of novel Toll-like receptor 8 (TLR8) therapeutics for the treatment of cancer, respiratory, and autoimmune diseases.